We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Clinical Dentistry

Journal Scan / Research · October 22, 2020

Neutrophil-to-Lymphocyte Ratio Represents a Valuable Biomarker for Risk Stratification in Patients With Oropharyngeal Cancer

Oral Diseases


Additional Info

Oral Diseases
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in HPV Status Era for Oropharyngeal Cancer
Oral Dis 2020 Sep 17;26(7)1384-1392, G Fanetti, D Alterio, G Marvaso, S Gandini, DP Rojas, C Gobitti, E Minatel, A Revelant, A Caroli, CM Francia, O Alessandro, M Pepa, SG Gugliandolo, A Starzyńska, J Polesel, E Vaccher, M Cossu Rocca, M Tagliabue, M Ansarin, V Lupato, V Giacomarra, A De Paoli, R Orecchia, G Franchin, BA Jereczek-Fossa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading